Mostafa Ahmed Arafa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mostafa Ahmed Arafa has a total of 86 co-authors. Here are the top co-authors by number of shared publications:
- Danny M. Rabah
King Saud University
13 shared publications - Karim Farhat
Department of Surgery, The Cancer Research Chair, College of Medicine, King Saud University, Riyadh, SAU
5 shared publications - Iman Wahdan
Department of Epidemiology, High Institute of Public Health, Alexandria University, Egypt
2 shared publications Abdelmalek Merdawy
Princess Al Johara AlIbrahim Center for Cancer Research, Prostate Cancer Unit, King Saud University, Riyadh, Saudi Arabia
1 shared publication- Abdulaziz Althunayan
Division of Urology, Department of Surgery, College of Medicine, King Saud University, Riyadh 12372, Saudi Arabia
1 shared publication - Abdulaziz Ibrahim Alrajeh
Ministry of Health, Riyadh Regional Lab and Blood Bank, Riyadh 12746, Saudi Arabia
1 shared publication
Latest Publications
- Open Access
- 5 November 2026
- Published by Springer Nature in Scientific Reports
Sun exposure and sun protection behaviors among Saudi adults: a national study of 11,491 participants
- 5 November 2026
- Published by Springer Nature in Scientific Reports
Open AccessSun exposure and sun protection behaviors among Saudi adults: a national study of 11,491 participants
- Open Access
Testing the Possible Protective Effect of Ivermectin on Bleomycin-Induced Pulmonary Fibrosis in Albino Rats: Histological and Immunohistochemical Study
Background and Objectives: Pulmonary fibrosis (PF) is an interstitial lung disease that leads to death and is characterized by excessive collagen deposition and tissue scarring. Bleomycin (BLM) is widely used to induce PF in rodent models, closely resembling human idiopathic pulmonary fibrosis. Ivermectin, a broad-spectrum antiparasitic agent, has recently attracted interest due to its reported anti-inflammatory and antifibrotic effects. The beneficial effects of ivermectin to treat PF may be attributed to suppressing the NLRP3 inflammasome. Ivermectin can cause acute toxicity, including convulsions, when overdosed in animals. In humans, it may induce neurological disorders, particularly in individuals with mutations in the ABCB1 gene. This study aimed to investigate the potential protective role of ivermectin against BLM-induced PF in rats. Materials and Methods: Forty adult male albino rats were randomly allocated into four groups (n = 10 each): control, ivermectin-treated (0.6 mg/kg, orally on days 0, 1, 7, and 8), BLM-treated (single intratracheal dose of 5 mg/kg), and BLM- and ivermectin-treated. Lung tissues were collected for histopathological analysis and Mallory trichrome staining to assess collagen deposition. Mast cell (MC) infiltration was assessed using toluidine blue. Immunohistochemistry for α-SMA and Ki-67 was used to evaluate myofibroblast and cell proliferation. Oxidative stress parameters, including serum total antioxidant capacity, lung glutathione and lung nitric oxide were measured. Results: Ivermectin treatment markedly attenuated BLM-induced lung fibrosis, showing reduced collagen accumulation, restoration of alveolar architecture, and decreased inflammatory cell infiltration. Immunohistochemical evaluation revealed decreased expression of α-SMA and Ki-67, while biochemical analyses demonstrated improved oxidative stress markers. Conclusions: Ivermectin significantly mitigates BLM-induced pulmonary fibrosis in rats through modulation of inflammation, suppression of myofibroblast proliferation, and reduction in oxidative stress and collagen deposition. These findings highlight ivermectin as a potential candidate for the management of fibrotic lung diseases, warranting further mechanistic and clinical investigations.
Open AccessTesting the Possible Protective Effect of Ivermectin on Bleomycin-Induced Pulmonary Fibrosis in Albino Rats: Histological and Immunohistochemical Study
Background and Objectives: Pulmonary fibrosis (PF) is an interstitial lung disease that leads to death and is characterized by excessive collagen deposition and tissue scarring. Bleomycin (BLM) is widely used to induce PF in rodent models, closely resembling human idiopathic pulmonary fibrosis. Ivermectin, a broad-spectrum antiparasitic agent, has recently attracted interest due to its reported anti-inflammatory and antifibrotic effects. The beneficial effects of ivermectin to treat PF may be attributed to suppressing the NLRP3 inflammasome. Ivermectin can cause acute toxicity, including convulsions, when overdosed in animals. In humans, it may induce neurological disorders, particularly in individuals with mutations in the ABCB1 gene. This study aimed to investigate the potential protective role of ivermectin against BLM-induced PF in rats. Materials and Methods: Forty adult male albino rats were randomly allocated into four groups (n = 10 each): control, ivermectin-treated (0.6 mg/kg, orally on days 0, 1, 7, and 8), BLM-treated (single intratracheal dose of 5 mg/kg), and BLM- and ivermectin-treated. Lung tissues were collected for histopathological analysis and Mallory trichrome staining to assess collagen deposition. Mast cell (MC) infiltration was assessed using toluidine blue. Immunohistochemistry for α-SMA and Ki-67 was used to evaluate myofibroblast and cell proliferation. Oxidative stress parameters, including serum total antioxidant capacity, lung glutathione and lung nitric oxide were measured. Results: Ivermectin treatment markedly attenuated BLM-induced lung fibrosis, showing reduced collagen accumulation, restoration of alveolar architecture, and decreased inflammatory cell infiltration. Immunohistochemical evaluation revealed decreased expression of α-SMA and Ki-67, while biochemical analyses demonstrated improved oxidative stress markers. Conclusions: Ivermectin significantly mitigates BLM-induced pulmonary fibrosis in rats through modulation of inflammation, suppression of myofibroblast proliferation, and reduction in oxidative stress and collagen deposition. These findings highlight ivermectin as a potential candidate for the management of fibrotic lung diseases, warranting further mechanistic and clinical investigations.
- Open Access
- 16 June 2025
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 73 (1) , 1-9
Acute medication poisoning in children at Alexandria Poison Centre, Egypt: an educational intervention
Background: Acute medication poisoning is a significant cause of preventable morbidity in children worldwide. Aim: This study aimed to assess the level of medication poisoning knowledge of children’s caregivers and their influencing factors, and to design, implement, and evaluate the effect of an educational session on caregivers’ level of knowledge regarding the prevention of acute medication poisoning among children. Methods: A predesigned structured interview questionnaire was used to assess caregivers’ knowledge before the session. The intervention was conducted as an educational session for 45 min, including the definition of poisoning, symptoms of poisoning, prevention and control of medication poisoning at home, first aid at home, especially for diabetic, cardiac, or hypertension medication poisoning, guidelines before and after administration of any medication, and storage duration and reconstitution of oral medications. The caregivers’ knowledge was reassessed by telephone using the same study tool 3 months after the educational session. Results: A total of 110 caregivers of medication-poisoned children were included. The study revealed that the mean total knowledge score increased from 2.65 ± 1.82 to 29.09 ± 3.76 after the educational session. Two factors were significantly associated with caregivers’ knowledge scores: low educational level and having more than two children (p = 0.016 and 0.034, respectively). Conclusions: A simple educational session significantly improved caregivers’ knowledge.
- 16 June 2025
- Published by Springer Nature in Egyptian Pediatric Association Gazette
- Vol. 73 (1) , 1-9
Open AccessAcute medication poisoning in children at Alexandria Poison Centre, Egypt: an educational intervention
Background: Acute medication poisoning is a significant cause of preventable morbidity in children worldwide. Aim: This study aimed to assess the level of medication poisoning knowledge of children’s caregivers and their influencing factors, and to design, implement, and evaluate the effect of an educational session on caregivers’ level of knowledge regarding the prevention of acute medication poisoning among children. Methods: A predesigned structured interview questionnaire was used to assess caregivers’ knowledge before the session. The intervention was conducted as an educational session for 45 min, including the definition of poisoning, symptoms of poisoning, prevention and control of medication poisoning at home, first aid at home, especially for diabetic, cardiac, or hypertension medication poisoning, guidelines before and after administration of any medication, and storage duration and reconstitution of oral medications. The caregivers’ knowledge was reassessed by telephone using the same study tool 3 months after the educational session. Results: A total of 110 caregivers of medication-poisoned children were included. The study revealed that the mean total knowledge score increased from 2.65 ± 1.82 to 29.09 ± 3.76 after the educational session. Two factors were significantly associated with caregivers’ knowledge scores: low educational level and having more than two children (p = 0.016 and 0.034, respectively). Conclusions: A simple educational session significantly improved caregivers’ knowledge.
- 14 March 2025
- Published by SAGE Publications in Mediterranean Journal of Nutrition and Metabolism
- Vol. 18 (2) , 118-126
Comparing machine learning model accuracy for predicting Vitamin D deficiency at different cut-offs in Saudi men
Background: Despite Saudi Arabia's sunny climate, vitamin D deficiency is prevalent. We aimed to utilize several machine learning algorithms to predict Vitamin D deficiency among Saudi men and identify correlated features. Methods: We collected data from the records of King Khalid University Hospital in Riyadh between 2019 and 2021. Variables included health conditions, race, blood pressure, BMI, blood glucose, lipid profile, and total 25-hydroxyvitamin D (25OHD) levels. Six ML algorithms (Support Vector Machine, decision tree, linear regression, gradient boosting, XGBoost, and random forest) were employed to construct models for both cutoff points of <75 nmol/L and <50 nmol/L. The dataset was randomly divided into the training set and validation set at a ratio of 8:2. The accuracy of the algorithm was tested using the ten-fold cross-validation method. Performance metrics such as accuracy, precision, recall, F1 score, and area under the precision-recall curve (PRC, AUC) were assessed and compared between the models for both categories. Results: Among 1700 Saudi men, 76.1% exhibited vitamin D deficiency (<75 nmol/l), with 52.5% deficient using an alternative cutoff (<50 nmol/l). Gradient boosting algorithm exhibited superior predictive accuracy, especially at the <75 nmol/L cutoff, outperforming the discrimination power of other algorithms for both classes. BMI emerged as the strongest predictor of vitamin D deficiency, followed by age and blood sugar results. The PRC, AUC for the <50 cutoff varies between 0.59 and 0.63 for the four classifiers (SVM, Linear regression, XGBoost, and Gradient boosting), whereas it reached 0.83 for the <75 cutoff. Conclusion: Vitamin D deficiency is prevalent among healthy Saudi Arabian men. ML algorithms have proven effective in identifying correlated features within this highly impacted population, enabling tailored interventions and appropriate preventive strategies to address vitamin D deficiency and insufficiency. This model's high accuracy can help identify individuals at risk without the need for costly and time-consuming blood tests.
- 14 March 2025
- Published by SAGE Publications in Mediterranean Journal of Nutrition and Metabolism
- Vol. 18 (2) , 118-126
Comparing machine learning model accuracy for predicting Vitamin D deficiency at different cut-offs in Saudi men
Background: Despite Saudi Arabia's sunny climate, vitamin D deficiency is prevalent. We aimed to utilize several machine learning algorithms to predict Vitamin D deficiency among Saudi men and identify correlated features. Methods: We collected data from the records of King Khalid University Hospital in Riyadh between 2019 and 2021. Variables included health conditions, race, blood pressure, BMI, blood glucose, lipid profile, and total 25-hydroxyvitamin D (25OHD) levels. Six ML algorithms (Support Vector Machine, decision tree, linear regression, gradient boosting, XGBoost, and random forest) were employed to construct models for both cutoff points of <75 nmol/L and <50 nmol/L. The dataset was randomly divided into the training set and validation set at a ratio of 8:2. The accuracy of the algorithm was tested using the ten-fold cross-validation method. Performance metrics such as accuracy, precision, recall, F1 score, and area under the precision-recall curve (PRC, AUC) were assessed and compared between the models for both categories. Results: Among 1700 Saudi men, 76.1% exhibited vitamin D deficiency (<75 nmol/l), with 52.5% deficient using an alternative cutoff (<50 nmol/l). Gradient boosting algorithm exhibited superior predictive accuracy, especially at the <75 nmol/L cutoff, outperforming the discrimination power of other algorithms for both classes. BMI emerged as the strongest predictor of vitamin D deficiency, followed by age and blood sugar results. The PRC, AUC for the <50 cutoff varies between 0.59 and 0.63 for the four classifiers (SVM, Linear regression, XGBoost, and Gradient boosting), whereas it reached 0.83 for the <75 cutoff. Conclusion: Vitamin D deficiency is prevalent among healthy Saudi Arabian men. ML algorithms have proven effective in identifying correlated features within this highly impacted population, enabling tailored interventions and appropriate preventive strategies to address vitamin D deficiency and insufficiency. This model's high accuracy can help identify individuals at risk without the need for costly and time-consuming blood tests.
- Open Access
- 19 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11798
The Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial
The current study investigated the impact of different doses of Nigella sativa seeds on the symptoms, the cluster of differentiation profile group, and inflammatory markers of mild COVID-19 cases. Methods: The study was a double-blind placebo-controlled clinical trial. Patients with mild and asymptomatic SARS-CoV-2 infection patients were randomly subdivided into seven subgroups: Group (GP) 1: received charcoal capsules as a control group, and GP 2: received three capsules of whole Nigella sativa seeds daily, two capsules in the morning and one in the evening; GP 3: received three capsules of whole Nigella sativa seeds every 12 h, GP 4: received five capsules in the morning and four capsules of whole Nigella sativa seeds in the evening, GP 5: received one capsule of Nigella sativa powder every 12 h; GP 6: received two capsules of Nigella sativa powder every 12 h; GP 7: received three capsules of Nigella sativa powder every 12 h; all treatment course was for ten days. Inflammatory parameters were assessed before and after interventions. Results: 262 subjects were included in the final analysis. No significant difference was detected regarding age, gender, and nationality. No significant differences were detected between the inflammatory marker in all groups. The WBCs showed a significant difference between before and after the intervention. While for procalcitonin, a significant difference was demonstrated in groups 1,4, and 6. Conclusions: The current randomized clinical trial did not reveal a significant effect of ten days of treatment with various doses of Nigella sativa on symptoms, differentiation profile, and inflammatory markers of patients with COVID-19. As a natural product, the effect of Nigella sativa on disease requires weeks to manifest itself.
- 19 September 2022
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (18) , 11798
Open AccessThe Effect of Short Treatment with Nigella Sativa on Symptoms, the Cluster of Differentiation (CD) Profile, and Inflammatory Markers in Mild COVID-19 Patients: A Randomized, Double-Blind Controlled Trial
The current study investigated the impact of different doses of Nigella sativa seeds on the symptoms, the cluster of differentiation profile group, and inflammatory markers of mild COVID-19 cases. Methods: The study was a double-blind placebo-controlled clinical trial. Patients with mild and asymptomatic SARS-CoV-2 infection patients were randomly subdivided into seven subgroups: Group (GP) 1: received charcoal capsules as a control group, and GP 2: received three capsules of whole Nigella sativa seeds daily, two capsules in the morning and one in the evening; GP 3: received three capsules of whole Nigella sativa seeds every 12 h, GP 4: received five capsules in the morning and four capsules of whole Nigella sativa seeds in the evening, GP 5: received one capsule of Nigella sativa powder every 12 h; GP 6: received two capsules of Nigella sativa powder every 12 h; GP 7: received three capsules of Nigella sativa powder every 12 h; all treatment course was for ten days. Inflammatory parameters were assessed before and after interventions. Results: 262 subjects were included in the final analysis. No significant difference was detected regarding age, gender, and nationality. No significant differences were detected between the inflammatory marker in all groups. The WBCs showed a significant difference between before and after the intervention. While for procalcitonin, a significant difference was demonstrated in groups 1,4, and 6. Conclusions: The current randomized clinical trial did not reveal a significant effect of ten days of treatment with various doses of Nigella sativa on symptoms, differentiation profile, and inflammatory markers of patients with COVID-19. As a natural product, the effect of Nigella sativa on disease requires weeks to manifest itself.
- 6 April 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (1) , 104-109
Stress Among Surgeons: Sources and Determinants
- 6 April 2021
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 84 (1) , 104-109
Stress Among Surgeons: Sources and Determinants
- Open Access
- 27 January 2021
- Published by Elsevier in Prostate International
- Vol. 9 (3) , 140-144
Effectiveness of magnetic resonance imaging–targeted biopsy for detection of prostate cancer in comparison with systematic biopsy in our countries with low prevalence of prostate cancer: our first experience after 3 years
- 27 January 2021
- Published by Elsevier in Prostate International
- Vol. 9 (3) , 140-144
Open AccessEffectiveness of magnetic resonance imaging–targeted biopsy for detection of prostate cancer in comparison with systematic biopsy in our countries with low prevalence of prostate cancer: our first experience after 3 years
- Open Access
- 1 January 2020
- Published by Medknow in Urology Annals
- Vol. 12 (4) , 335-340
Factors influencing urology physicians in Saudi Arabia for choosing their subspecialty program
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- 1 January 2020
- Published by Medknow in Urology Annals
- Vol. 12 (4) , 335-340
Open AccessFactors influencing urology physicians in Saudi Arabia for choosing their subspecialty program
J Indian Prosthodont Soc, Official publication of Indian Prosthodontic Society
- Open Access
- 20 February 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-6
Vitamin D status and its correlates in Saudi male population
Vitamin-D deficiency is a universal health problem caused primarily by inadequate exposure to sunlight. This study aimed to assess the vitamin D status and investigate the factors affecting vitamin D distribution among Saudi males. A cross-sectional study was conducted at the King Saud University Medical City from December 2015 to August 2016. Saudi males attending the outpatient primary health care clinics were invited to participate in the study. Data were collected on the current and past health status along with biochemical investigations for total 25-hydroxyvitamin D (25OHD), blood sugar, and cholesterol. Majority of the participants (76.1%) had vitamin D deficiency. Blood sugar level, age, and cholesterol level were the most significant factors associated with vitamin D status. The highest percentage of deficiency was observed in the youngest age group (30-40 years). With increasing age, the percentage of deficiency decreased significantly. Those with normal blood sugar and cholesterol level had higher serum vitamin D levels compared to those with diabetes and hypercholesterolemia. Vitamin D deficiency is still endemic in Saudi Arabia, particularly among younger males and those with diabetes and hypercholesterolemia. Vitamin D screening, supplementations, and vitamin D-fortified foods should be provided especially for these groups.
- 20 February 2019
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-6
Open AccessVitamin D status and its correlates in Saudi male population
Vitamin-D deficiency is a universal health problem caused primarily by inadequate exposure to sunlight. This study aimed to assess the vitamin D status and investigate the factors affecting vitamin D distribution among Saudi males. A cross-sectional study was conducted at the King Saud University Medical City from December 2015 to August 2016. Saudi males attending the outpatient primary health care clinics were invited to participate in the study. Data were collected on the current and past health status along with biochemical investigations for total 25-hydroxyvitamin D (25OHD), blood sugar, and cholesterol. Majority of the participants (76.1%) had vitamin D deficiency. Blood sugar level, age, and cholesterol level were the most significant factors associated with vitamin D status. The highest percentage of deficiency was observed in the youngest age group (30-40 years). With increasing age, the percentage of deficiency decreased significantly. Those with normal blood sugar and cholesterol level had higher serum vitamin D levels compared to those with diabetes and hypercholesterolemia. Vitamin D deficiency is still endemic in Saudi Arabia, particularly among younger males and those with diabetes and hypercholesterolemia. Vitamin D screening, supplementations, and vitamin D-fortified foods should be provided especially for these groups.
- Open Access
- 10 December 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 8 (6) , 447-449
With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?
Incidence rate for prostate cancer in the Arab World is significantly lower than United States and Europe, it ranges from 5.5% to 39.2%. However, the incidence and the number of deaths is expected to increase. In Saudi Arabia, the crude incidence rate and age standardized incidence rate of prostate cancer are reported to be steadily increasing in between 2001-2008. Only two screening trials were attempted in 2001 and 2009 which yielded an incidence rate of 1.17% and 2.5% respectively. Men in the Arab world are sharing a common characteristic of poor knowledge and poor attitude towards prostate cancer examination and screening practices. They are ill-informed about the PSA test’s strengths and drawbacks because the doctors are not talking to them about the importance of counselling. Men should be encouraged to do PSA testing before the age of 50 and till the age of 70 years. This could be achieved by enhancing their attitude and enriching the knowledge of the physicians towards PSA testing, harms and benefits, through shared decision making, which would increase men’s knowledge scores, reduced their decisional conflict and promote greater involvement in decision making.
- 10 December 2017
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 8 (6) , 447-449
Open AccessWith increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?
Incidence rate for prostate cancer in the Arab World is significantly lower than United States and Europe, it ranges from 5.5% to 39.2%. However, the incidence and the number of deaths is expected to increase. In Saudi Arabia, the crude incidence rate and age standardized incidence rate of prostate cancer are reported to be steadily increasing in between 2001-2008. Only two screening trials were attempted in 2001 and 2009 which yielded an incidence rate of 1.17% and 2.5% respectively. Men in the Arab world are sharing a common characteristic of poor knowledge and poor attitude towards prostate cancer examination and screening practices. They are ill-informed about the PSA test’s strengths and drawbacks because the doctors are not talking to them about the importance of counselling. Men should be encouraged to do PSA testing before the age of 50 and till the age of 70 years. This could be achieved by enhancing their attitude and enriching the knowledge of the physicians towards PSA testing, harms and benefits, through shared decision making, which would increase men’s knowledge scores, reduced their decisional conflict and promote greater involvement in decision making.